Health & Fitness
Health and Fitness
Health and Fitness
Fri, February 27, 2009
Thu, February 26, 2009 BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2009
ELMWOOD PARK, N.J.--([ BUSINESS WIRE ])--BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the first quarter of fiscal 2009 before the open of market trading on Thursday, March 5, 2009. The Company's earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.
The live Web cast will be available at the Company's corporate Web site, [ www.bioreference.com ] and through [ www.streetevents.com ]. To listen to the live call please go to the Web site ten minutes before the conference call is scheduled to begin. You will need to register as well as download and install any necessary audio software. The Web cast will be archived, on both Web sites, for 30 days following the call.
About BioReference Laboratories, Inc.
BRLI is the third largest full service laboratory in the United States and the largest independent laboratory in the Northeastern market, primarily a clinical testing lab servicing physician offices with concentrations in the focused markets of esoteric testing, molecular diagnostic, anatomical pathology and correctional health care. BRLI operates as a national oncology laboratory under its GenPath label. Better science, superior technology and better service have enabled GenPath to earn a reputation as one of the premier hematopathology laboratories in the country. GeneDx, a wholly owned subsidiary, is the BRLI genetics laboratory and is typically recognized as the leading laboratory for testing of rare genetic diseases; GeneDx has now become a technology leader with GenomeDx, based on a CGH array platform and its NextGen sequence offerings that are and will be disease specific.
